These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7910053)

  • 21. Polyethylene glycol-modified interleukin-2 and thymosin alpha 1 in human immunodeficiency virus type 1 infection.
    Ramachandran R; Katzenstein DA; Winters MA; Kundu SK; Merigan TC
    J Infect Dis; 1996 Apr; 173(4):1005-8. PubMed ID: 8603940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.
    Janssen HL; Berk L; Heijtink RA; ten Kate FJ; Schalm SW
    Hepatology; 1993 Mar; 17(3):383-8. PubMed ID: 8444411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Agents for treating human immunodeficiency virus infection.
    Acosta EP; Fletcher CV
    Am J Hosp Pharm; 1994 Sep; 51(18):2251-67; quiz 2286-7. PubMed ID: 7801986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined treatment with thymosin-alpha1 and low dose interferon-alpha after dacarbazine in advanced melanoma.
    Rasi G; Terzoli E; Izzo F; Pierimarchi P; Ranuzzi M; Sinibaldi-Vallebona P; Tuthill C; Garaci E
    Melanoma Res; 2000 Apr; 10(2):189-92. PubMed ID: 10803720
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of alpha-interferon in patients with human immunodeficiency virus infection.
    Lane HC
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):46-52. PubMed ID: 1948129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
    N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-alpha and zidovudine.
    Berglund O; Engman K; Ehrnst A; Andersson J; Lidman K; Akerlund B; Sönnerborg A; Strannegård O
    J Infect Dis; 1991 Apr; 163(4):710-5. PubMed ID: 1672701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of zidovudine-resistant human immunodeficiency virus isolated from patients before, during, and after therapy.
    Land S; McGavin C; Lucas R; Birch C
    J Infect Dis; 1992 Nov; 166(5):1139-42. PubMed ID: 1402026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party.
    Bartlett JA; Benoit SL; Johnson VA; Quinn JB; Sepulveda GE; Ehmann WC; Tsoukas C; Fallon MA; Self PL; Rubin M
    Ann Intern Med; 1996 Aug; 125(3):161-72. PubMed ID: 8686973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS).
    Kovacs JA; Deyton L; Davey R; Falloon J; Zunich K; Lee D; Metcalf JA; Bigley JW; Sawyer LA; Zoon KC
    Ann Intern Med; 1989 Aug; 111(4):280-7. PubMed ID: 2757312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon alpha in the treatment of AIDS-related Kaposi's sarcoma.
    Mitsuyasu RT
    Br J Haematol; 1991 Oct; 79 Suppl 1():69-73. PubMed ID: 1931714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus.
    Schwartz DH; Skowron G; Merigan TC
    J Acquir Immune Defic Syndr (1988); 1991; 4(1):11-23. PubMed ID: 1670586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group.
    Spruance SL; Pavia AT; Mellors JW; Murphy R; Gathe J; Stool E; Jemsek JG; Dellamonica P; Cross A; Dunkle L
    Ann Intern Med; 1997 Mar; 126(5):355-63. PubMed ID: 9054279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group.
    Fischl MA; Stanley K; Collier AC; Arduino JM; Stein DS; Feinberg JE; Allan JD; Goldsmith JC; Powderly WG
    Ann Intern Med; 1995 Jan; 122(1):24-32. PubMed ID: 7985892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The treatment of antiretroviral-naive subjects with the 3TC/zidovudine combination: a review of North American (NUCA 3001) and European (NUCB 3001) trials.
    Eron JJ
    AIDS; 1996 Dec; 10 Suppl 5():S11-9. PubMed ID: 9030391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study.
    Shepherd FA; Beaulieu R; Gelmon K; Thuot CA; Sawka C; Read S; Singer J
    J Clin Oncol; 1998 May; 16(5):1736-42. PubMed ID: 9586886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice.
    Mastino A; Favalli C; Grelli S; Innocenti F; Garaci E
    Cell Immunol; 1991 Mar; 133(1):196-205. PubMed ID: 1991327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: a prospective, multicenter, randomized, open-label study.
    Kim BH; Lee YJ; Kim W; Yoon JH; Jung EU; Park SJ; Kim YJ; Lee HS
    Scand J Gastroenterol; 2012 Sep; 47(8-9):1048-55. PubMed ID: 22726105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.
    Collier AC; Coombs RW; Schoenfeld DA; Bassett RL; Timpone J; Baruch A; Jones M; Facey K; Whitacre C; McAuliffe VJ; Friedman HM; Merigan TC; Reichman RC; Hooper C; Corey L
    N Engl J Med; 1996 Apr; 334(16):1011-7. PubMed ID: 8598838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.
    Lane HC; Davey V; Kovacs JA; Feinberg J; Metcalf JA; Herpin B; Walker R; Deyton L; Davey RT; Falloon J
    Ann Intern Med; 1990 Jun; 112(11):805-11. PubMed ID: 1971503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.